U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07786012) titled 'BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)' on Aug. 21.

Brief Summary: In this study the researchers are randomizing pregnant patients coming for elective cesarean delivery to receive either intrathecal buprenorphine or morphine for their analgesia.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Cesarean Delivery

Intervention: DRUG: buprenorphine

60 mcg buprenorphine intrathecal

DRUG: morphine

125mcg morphine intrathecal

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Icahn School of Medicine at Mount Sinai

Information provided by (Responsible Party): Daniel Katz, Icahn School of ...